Baroness Delyth Morgan is Chief Executive of Breast Cancer Now

About Baroness Delyth Morgan

Delyth became Chief Executive of Breakthrough Breast Cancer in 1996, when the charity was in its infancy. Since then, she has been committed to stopping women dying from breast cancer, working at the forefront of this critical field in a number of different capacities.  

As CEO of Breakthrough for 10 years, she turned the organisation into the fastest growing charity in the sector and created a dynamic and ambitious brand that put breast cancer firmly on the public agenda.

In 2007, Delyth was appointed to Government. She served as Children’s Minister, Intellectual Property Minister and Quality and Government spokesperson for the Department of Work and Pensions in the House of Lords.

She became Chief Executive of Breast Cancer Campaign in 2011, leading the charity in its mission to find the cures for breast cancer and conducting the first Gap Analysis to identify the critical gaps in breast cancer research and knowledge.  

Breast Cancer Now

In 2014, Delyth played a pivotal role in the merger of Breast Cancer Campaign and Breakthrough Breast Cancer, working with trustees to define and establish a new organisation committed to the ambition that, by 2050, everyone who develops breast cancer will live.

In April 2015 Delyth became Chief Executive of Breast Cancer Now, the UK’s largest breast cancer charity.

Leading Breast Cancer Now is the opportunity to finish the job I started 20 years ago – to finally stop women dying from breast cancer. Collaboration and enterprise will be essential; we cannot do it alone. We need anyone and everyone who is involved in and affected by breast cancer to stand with us.

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now

Delyth now sits in the House of Lords as an independent peer. She is a Fellow of University College London and Honorary Fellow of the Institute of Cancer Research and Cardiff University.

She is also Patron of Pancreatic Cancer UK and the Sheila McKechnie Foundation, and Honorary President of Cancer52. In June 2015, she was appointed Chair of the National Cancer Research Institute (NCRI).

Follow Delyth on social media

Follow Delyth on Twitter @delythjmorgan